Immune Dysfunction linking hyperglycemia with periodontitis in Diabetes Management
Harini Venkata Subbiah1, Polani Ramesh Babu2, Usha Subbiah1*, Daniel Rajendran T3, Vinod Kumar P3
Journal of Angiotherapy 5(2) 1-7 https://doi.org/10.25163/angiotherapy.52221532819191221
Submitted: 28 November 2021 Revised: 08 December 2021 Published: 19 December 2021
Abstract
Background: Periodontitis is a progressive inflammatory disease affecting the gums and supporting tissues, often worsened by diabetes. Its pathogenesis involves pathogenic bacteria and the host’s immune response. Hyperglycemia in diabetes elevates glucose in saliva and gingival crevicular fluid (GCF), fostering bacterial growth and periodontal tissue damage. This study investigates the mechanisms linking immune dysfunction, periodontitis, and diabetes, emphasizing advanced glycation end products (AGEs), cytokine production, and oxidative stress. Methods: We performed a comprehensive literature review to analyze the relationships among hyperglycemia, AGEs, inflammatory cytokines, oxidative stress, and periodontal damage. Data were sourced from studies examining diabetes' impact on periodontal health, focusing on AGEs and their receptor (RAGE), the RANKL/OPG system, neutrophil function, oxidative stress, hyperlipidemia, collagen synthesis, and antimicrobial peptides. Results: Persistent hyperglycemia leads to increased AGEs, which interact with RAGE to heighten inflammatory responses and oxidative stress. This interaction triggers cytokine release and disrupts the RANKL/OPG balance, enhancing osteoclast activity and bone resorption. Additionally, oxidative stress from elevated reactive oxygen species (ROS) and hyperlipidemia worsens periodontal damage. Neutrophil function in diabetic patients can be dysregulated, with either impaired or excessive activity contributing to tissue degradation. Changes in collagen synthesis and antimicrobial peptide levels further aggravate periodontal disease in diabetes. Conclusion: Hyperglycemia and periodontitis involve complex mechanisms, including AGE-induced inflammation, oxidative stress, and altered bone remodeling. Effective diabetes management is essential to mitigate its impact on periodontal health. Understanding these mechanisms can inform targeted interventions, improving treatment outcomes for patients with both conditions. Future research should focus on strategies addressing these interconnected factors for enhanced periodontal and diabetic care.
Keywords: Immune Dysfunction, Periodontitis, Diabetes Mellitus, Advanced Glycation End Products, Cytokine Production
References
Akkaloori, A., Parthasarathi, P., Anjum, M. S., Gadde, P., Mocherla, M., & Rao, Y. (2014). Association between chronic periodontal disease and cardiovascular risk factor hyperlipidemia. Journal of Dr. NTR University of Health Sciences, 3(4), 249. https://doi.org/10.4103/2277-8632.146628
Betteridge, D. J. (2000). What is oxidative stress? Metabolism, 49(2), 3-8. https://doi.org/10.1016/S0026-0495(00)80077-3
Celec, P. (2017). Oxidative stress and antioxidants in the diagnosis and therapy of periodontitis. Frontiers in Physiology, 8, 1055. https://doi.org/10.3389/fphys.2017.01055
Choi, Y.-H., McKeown, R. E., Mayer-Davis, E. J., Liese, A. D., Song, K.-B., & Merchant, A. T. (2011). Association between periodontitis and impaired fasting glucose and diabetes. Diabetes Care, 34(2), 381-386. https://doi.org/10.2337/dc10-1354
Fentoglu, O., & Bozkurt, F. Y. (2008). The bi-directional relationship between periodontal disease and hyperlipidemia. European Journal of Dentistry, 2(02), 142-149. https://doi.org/10.1055/s-0039-1697370
Goldberg, I. J. (2001). Diabetic dyslipidemia: Causes and consequences. Journal of Clinical Endocrinology & Metabolism, 86(3), 965-971. https://doi.org/10.1210/jcem.86.3.7304
Graves, D. (2008). Cytokines that promote periodontal tissue destruction. Journal of Periodontology, 79, 1585-1591. https://doi.org/10.1902/jop.2008.080183
Grover, H. S., & Luthra, S. (2013). Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease. Journal of Indian Society of Periodontology, 17(3), 292. https://doi.org/10.4103/0972-124X.115642
Iacopino, A. M. (2001). Periodontitis and diabetes interrelationships: Role of inflammation. Annals of Periodontology, 6(1), 125-137. https://doi.org/10.1902/annals.2001.6.1.125
Lalla, R. V., & D'Ambrosio, J. A. (2001). Dental management considerations for the patient with diabetes mellitus. Journal of the American Dental Association, 132(10), 1425-1432. https://doi.org/10.14219/jada.archive.2001.0059
Lan, C.-C. E., Wu, C.-S., Huang, S.-M., et al. (2011). High-glucose environment inhibits p38MAPK signaling and reduces human β-3 expression in keratinocytes. Molecular Medicine, 17(7), 771-779. https://doi.org/10.2119/molmed.2010.00091
Lei, L., Li, H., Yan, F., & Xiao, Y. (2013). Hyperlipidemia impaired innate immune response to periodontal pathogen Porphyromonas gingivalis in apolipoprotein E knockout mice. PLoS ONE, 8(8), e71849. https://doi.org/10.1371/journal.pone.0071849
Liu, W., & Zhang, X. (2015). Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues. Molecular Medicine Reports, 11(5), 3212-3218. https://doi.org/10.3892/mmr.2015.3152
Lutfioglu, M., Aydogdu, A., Atabay, V. E., Sakallioglu, E. E., & Avci, B. (2017). Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia. Brazilian Oral Research, 31. https://doi.org/10.1590/1807-3107bor-2017.vol31.0110
Mahamed, D. A., Marleau, A., Alnaeeli, M., et al. (2005). G (−) Anaerobes-Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice. Diabetes, 54(5), 1477-1486. https://doi.org/10.2337/diabetes.54.5.1477
Manouchehr-Pour, M., Spagnuolo, P. J., Rodman, H. M., & Bissada, N. F. (1981). Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. Journal of Periodontology, 52(8), 410-415. https://doi.org/10.1902/jop.1981.52.8.410
MR, P., Surlin, P., Rauten, A. M., Dragomir, L., & Olteanu, M. (2014). Histological analysis of collagen fibers in patients with diabetes mellitus and periodontal disease. Journal of Cytology & Histology, 4, 2. https://doi.org/10.4172/2157-7099.S4-008
Nguyen, G. T., Green, E. R., & Mecsas, J. (2017). Neutrophils to the ROScue: Mechanisms of NADPH oxidase activation and bacterial resistance. Frontiers in Cellular and Infection Microbiology, 7, 373. https://doi.org/10.3389/fcimb.2017.00373
Ochanji, A. A., Matu, N. K., & Mulli, T. K. (2017). Association of salivary RANKL and osteoprotegerin levels with periodontal health. Clinical and Experimental Dental Research, 3(2), 45-50. https://doi.org/10.1002/cre2.49
Ohlrich, E. J., Cullinan, M. P., & Leichter, J. W. (2010). Diabetes, periodontitis, and the subgingival microbiota. Journal of Oral Microbiology, 2(1), 5818. https://doi.org/10.3402/jom.v2i0.5818
Pietropaoli, D., Tatone, C., D'Alessandro, A. M., & Monaco, A. (2010). Possible involvement of advanced glycation end products in periodontal diseases. International Journal of Immunopathology and Pharmacology, 23(3), 683-691. https://doi.org/10.1177/039463201002300301
Preshaw, P. M., & Bissett, S. M. (2019). Periodontitis and diabetes. British Dental Journal, 227(7), 577-584. https://doi.org/10.1038/s41415-019-0794-5
Rajeev, K., Karthika, R., Mythili, R., Krishnan, V., & Nirmal, M. (2011). Role of receptors of advanced glycation end-products (RAGE) in type 2 diabetic and non-diabetic individuals with chronic periodontal disease: An immunohistochemical study. Journal of Investigative and Clinical Dentistry, 2(4), 287-292. https://doi.org/10.1111/j.2041-1626.2011.00079.x
Ryan, M. E., Carnu, O., & Kamer, A. (2003). The influence of diabetes on the periodontal tissues. Journal of the American Dental Association, 134, 34S-40S. https://doi.org/10.14219/jada.archive.2003.0370
Sharma, M., Jindal, R., Siddiqui, M. A., & Wangnoo, S. K. (2016). Diabetes and periodontitis: A medical perspective. Journal of International Clinical Dental Research Organization, 8(1), 3. https://doi.org/10.4103/2231-0754.176244
Shetty, N., Thomas, B., & Ramesh, A. (2008). Comparison of neutrophil functions in diabetic and healthy subjects with chronic generalized periodontitis. Journal of Indian Society of Periodontology, 12(2), 41. https://doi.org/10.4103/0972-124X.44089
Silva, N., Abusleme, L., Bravo, D., et al. (2015). Host response mechanisms in periodontal diseases. Journal of Applied Oral Science, 23(3), 329-355. https://doi.org/10.1590/1678-775720140259
Tanaka, Y., Nakayamada, S., & Okada, Y. (2005). Osteoblasts and osteoclasts in bone remodeling and inflammation. Current Drug Targets - Inflammation & Allergy, 4(3), 325-328. https://doi.org/10.2174/1568010054022015
Tawfig, N. (2016). Proinflammatory cytokines and periodontal disease. Journal of Dental Problems & Solutions, 3(1), 12-17. https://doi.org/10.17352/2394-8418.000026
Taylor, G. W., & Borgnakke, W. S. (2008). Periodontal disease: Associations with diabetes, glycemic control and complications. Oral Diseases, 14(3), 191-203. https://doi.org/10.1111/j.1601-0825.2008.01442.x
Vieira Ribeiro, F., de Mendonça, A. C., Santos, V. R., Bastos, M. F., Figueiredo, L. C., & Duarte, P. M. (2011). Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. Journal of Periodontology, 82(8), 1187-1196. https://doi.org/10.1902/jop.2011.100643
Vlassara, H., & Uribarri, J. (2014). Advanced glycation end products (AGE) and diabetes: Cause, effect, or both? Current Diabetes Reports, 14(1), 1-10. https://doi.org/10.1007/s11892-013-0453-1
Volpe, C. M. O., Villar-Delfino, P. H., Dos Anjos, P. M. F., & Nogueira-Machado, J. A. (2018). Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death & Disease, 9(2), 1-9. https://doi.org/10.1038/s41419-017-0135-z
Wu, Y.-Y., Xiao, E., & Graves, D. T. (2015). Diabetes mellitus related bone metabolism and periodontal disease. International Journal of Oral Science, 7(2), 63-72. https://doi.org/10.1038/ijos.2015.2
Yilmaz, D., Caglayan, F., Buber, E., et al. (2018). Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis. Clinical Oral Investigations, 22(5), 2135-2140. https://doi.org/10.1007/s00784-018-2469-z
Zainab, A. J. A. A., Ashish, N., & Ragnath, V. (2019). Salivary levels of antimicrobial peptides in chronic periodontitis patients with type 2 diabetes. Journal of the International Academy of Periodontology, 21(1), 36-44.
View Dimensions
View Altmetric
Save
Citation
View
Share